Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R.
.
.
.
. McCarthy CG, et al. JCI Insight. 2021 Sep 9:149037. doi: 10.1172/jci.insight.149037. Online ahead of print. JCI Insight. 2021. PMID: 34499623
.
.
.
JAMA. 2021 Sep 8. doi: 10.1001/jama.2021.15494. Online ahead of print. JAMA. 2021. PMID: 34495304 No abstract available.
.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
